# Maternal and Fetal Outcomes in Early-Onset vs. Late-Onset Preeclampsia: A Retrospective Study at a Tertiary Care Institute in India

**Authors:** Uditi S Harjai, Ketaki K Junnare

PMC · DOI: 10.7759/cureus.102711 · Cureus · 2026-01-31

## TL;DR

This study compares maternal and fetal outcomes in early-onset and late-onset preeclampsia, finding that early-onset is more severe and leads to worse neonatal outcomes.

## Contribution

The study highlights the distinct clinical risks and outcomes of early-onset preeclampsia, particularly its association with IVF and severe neonatal complications.

## Key findings

- Early-onset preeclampsia was strongly linked to IVF treatment and severe maternal disease.
- Early-onset cases had higher rates of preterm delivery, low birth weight, and NICU admissions.
- Neonatal outcomes were significantly worse in early-onset preeclampsia compared to late-onset.

## Abstract

Background

Preeclampsia is a hypertensive disorder of pregnancy associated with significant maternal and perinatal morbidity and mortality. Distinguishing between early- and late-onset preeclampsia is crucial due to differences in pathophysiology, severity, and outcomes. This study aimed to evaluate and contrast clinical characteristics, complications, and outcomes between the two types.

Aim & objective

The aim of the study is to compare the maternal and fetal outcomes in pregnancies complicated by early-onset preeclampsia (before 34 weeks) versus late-onset preeclampsia (34 weeks or later) and identify specific clinical risks and prognostic implications associated with the timing of disease onset.

Materials & methods

A hospital-based retrospective observational study was conducted at Smt. Kashibai Navale Medical College and General Hospital, Pune, from November 2022 to October 2024. A total of 88 pregnant women diagnosed with preeclampsia were categorized into early-onset (<34 weeks) and late-onset (≥34 weeks) groups. Clinical data were extracted from medical records and analyzed using chi-square and Fisher’s exact tests to assess associations between disease onset and maternal/neonatal outcomes.

Results

Among the 88 cases, early-onset and late-onset preeclampsia were nearly evenly distributed (48.9% vs. 51.1%). Severe preeclampsia was significantly more frequent in the early-onset group (93.0% vs. 62.2%, p=0.001). Early-onset preeclampsia was strongly associated with the cases who underwent IVF (in vitro fertilization) treatment (p=0.001). Early-onset cases had significantly higher rates of preterm delivery (<34 weeks: 76.7%), extremely low birth weight (<1.5 kg: 65.1%), intrauterine death (20.9%, p=0.002), NICU (Neonatal Intensive Care Unit) admissions (p<0.001), and low APGAR scores (p<0.001). Maternal complications were more frequent in early-onset cases, although the difference was not statistically significant.

Discussion

The study affirms that early-onset preeclampsia is associated with great severity disease and significantly poorer neonatal outcomes, especially in terms of prematurity, fetal growth restriction, and neonatal morbidity. IVF emerged as a notable risk factor for early-onset pre-eclampsia. Despite higher complication rates, maternal mortality was zero in this cohort.

Conclusion

Early-onset preeclampsia poses greater risks to both mother and fetus than late-onset disease. Identifying high-risk pregnancies, especially IVF conceptions, and implementing timely interventions are essential to improving outcomes. Enhanced surveillance and preparedness of neonatal intensive care are particularly critical in early-onset cases.

## Linked entities

- **Diseases:** preeclampsia (MONDO:0005081)

## Full-text entities

- **Genes:** PGF (placental growth factor) [NCBI Gene 5228] {aka D12S1900, PGFL, PIGF, PLGF, PlGF-2, SHGC-10760}
- **Diseases:** extremely preterm birth (MESH:D047928), cardiovascular disease (MESH:D002318), PIH (MESH:D046110), defective placentation (MESH:D010922), Eclampsia (MESH:D004461), HELLP (MESH:D017359), hematological abnormalities (MESH:D006402), Hypertension (MESH:D006973), autoimmune or connective tissue disorders (MESH:D003240), Intrauterine death (MESH:D003643), cerebral hemorrhage (MESH:D002543), placental insufficiency (MESH:D010927), DIC (MESH:D004211), chronic (MESH:D002908), IVF (MESH:C566179), LSCS (MESH:C537538), hepatic involvement (MESH:D056486), prematurity (MESH:C536271), PPH (MESH:D006473), uteroplacental dysfunction (MESH:D006331), FSB (MESH:D050497), renal disorders (MESH:D007674), necrotizing enterocolitis (MESH:D020345), -induced (MESH:D000092582), pulmonary edema (MESH:D011654), Preeclampsia (MESH:D011225), chronic kidney disease (MESH:D051436), neurological complications (MESH:D002493), irritability (MESH:D001523), endothelial dysfunction (MESH:D014652), diabetes mellitus (MESH:D003920), epigastric pain (MESH:D010146), visual disturbances (MESH:D014786), congenital anomalies (MESH:D000013), metabolic syndrome (MESH:D024821), IUGR (MESH:D005317), preeclamptic (MESH:C538543), hemolysis (MESH:D006461), abruption (MESH:D000037), respiratory distress syndrome (MESH:D012128), proteinuria (MESH:D011507), acute renal failure (MESH:D058186), end-organ dysfunction (MESH:D009102), intraventricular hemorrhage (MESH:D000074042), hemorrhagic (MESH:D006470), obesity (MESH:D009765)
- **Chemicals:** creatinine (MESH:D003404)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12952277/full.md

## References

17 references — full list in the complete paper: https://tomesphere.com/paper/PMC12952277/full.md

---
Source: https://tomesphere.com/paper/PMC12952277